Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5685 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-006 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2010-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_085a0b11deefa4a96c5e61c53d0724b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2cf1a6a0410bd7e6511487d226d3792 |
publicationDate |
2012-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2393323-A1 |
titleOfInvention |
Fulvestrant in a dosage of 500 mg for the treatment of advanced breast cancer |
abstract |
The present invention relates to fulvestrant at a dosage of 500 mg for use in the treatment of a postmenopausal woman with advanced breast cancer who has progressed or resorted to endocrine therapy. |
priorityDate |
2009-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |